Acadia Healthcare Company, Inc.
ACHC· Nasdaq
Released Oct 30, 2024, after the close
10-Q filed Oct 30, 2024, 30 days after period end · 0000950170-24-119044
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $815.63M | $750.33M | $666.73M | $587.56M |
| Net Income | $68.13M | -$217.71M | $71.10M | $66.13M |
| EPS Diluted |
Acadia Healthcare Company, Inc. · CIK 1520697 · Engraved from SEC EDGAR
| $0.74 |
| -$2.39 |
| $0.78 |
| $0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.